Late-onset panhypopituitarism in a 72-year-old male patient treated with ipilimumab for metastatic melanoma: a case report.

Vancieri, G; Bellia, A; Lauro, D

Vancieri, G; Bellia, A; Lauro, D.

Afiliación

Vancieri G; Division of Endocrinology and Diabetology, Department of Systems Medicine, University of Rome "Tor Vergata", Rome, Italy.
Bellia A; Division of Endocrinology and Diabetology, Department of Systems Medicine, University of Rome "Tor Vergata", Rome, Italy.
Lauro D; Division of Endocrinology and Diabetology, Department of Systems Medicine, University of Rome "Tor Vergata", Rome, Italy. d.lauro@med.uniroma2.it.

J Endocrinol Invest ; 39(7): 805-6, 2016 Jul.

Article en En | MEDLINE | ID: mdl-26883763

Asunto(s)

Anticuerpos Monoclonales/efectos adversos; Hipopituitarismo/inducido químicamente; Hipopituitarismo/diagnóstico; Melanoma/tratamiento farmacológico; Edad de Inicio; Anciano; Humanos; Ipilimumab; Masculino; Melanoma/secundario

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Hipopituitarismo / Melanoma / Anticuerpos Monoclonales Límite: Aged / Humans / Male Idioma: En Revista: J Endocrinol Invest Año: 2016 Tipo del documento: Article País de afiliación: Italia

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google